Keywords

On this page readers can obtain a listing of documents classified by keywords. Click on the bookshelf icon of a keyword to obtain the concerned documents or to return to the main list of keywords.
All - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
Expand the sub-collections menu.
36 documents on 1 page
 
 
 
Open this document and view its content

A70/23 - Dispositif des États Membres concernant les produits médicaux de qualité inférieure/faux/ faussement étiquetés/falsifiés/contrefaits. Rapport du Directeur général. Soixante-Dixième Assemblée mondiale de la Santé, 2017. (inclus : A70/23 Add.1 - Examen du dispositif des États Membres concernant les produits médicaux de qualité inférieure/faux/faussement étiquetés/falsifiés/contrefaits) (avec Appendice 1: Orientations pour l’élaboration d’un plan national en vue de prévenir, de détecter et de combattre les mesures, activités et comportements à l’origine de produits médicaux de qualité inférieure/faux/faussement étiquetés/falsifiés/contrefaits. Appendice 2: Technologies d’authentification disponibles pour la prévention et la détection des produits médicaux de qualité inférieure/faux/faussement étiquetés/falsifiés/contrefaits. Appendice 3: Dispositif OMS des États Membres concernant les produits médicaux de qualité inférieure/faux/faussement étiquetés/falsifiés/contrefaits: Définitions de travail) [Arabic] [Chinese] [English] [Russian] [Spanish]

Year:

2017;

Pages:

46;


Related documents:

Regions:

 
Open this document and view its content

A70/23 - Mecanismo de Estados Miembros sobre productos médicos de calidad subestándar, espurios, de etiquetado engañoso, falsificados o de imitación. Informe de la Directora General. La 70.ª Asamblea Mundial de la Salud, 2017. (incluido A70/23 Add.1 - Examen del mecanismo de Estados Miembros sobre productos médicos de calidad subestándar, espurios, de etiquetado engañoso, falsificados o de imitación) (con Apéndice 1: Orientaciones sobre la elaboración de un plan nacional para prevenir, detectar y contrarrestar las medidas, actividades y comportamientos que originan productos médicos de calidad subestándar, espurios, de etiquetado engañoso, falsificados o de imitación (SSFFC). Apéndice 2: Tecnologías de autenticación disponibles para la prevención y la detección de productos médicos SSFFC. Apéndice 3: Mecanismo de estados miembros de la oms sobre productos médicos de calidad subestándar, espurios, de etiquetado engañoso, falsificados o de imitación (SSFFC): Definiciones funcionales) [Arabic] [Chinese] [English] [French] [Russian]

Year:

2017;

Pages:

44;


Related documents:

Regions:

 
Open this document and view its content

A70/23 - Member State Mechanism on Substandard/Spurious/Falsely-labelled/Falsified/ Counterfeit Medical Products. Report by the Director-general. Seventieth World Health Assembly, 2017. (With A70/23 Add.1 - Review of the Member State Mechanism On Substandard/Spurious/Falsely-labelled/ Falsified/Counterfeit Medical Products) (with Appendix 1: Guidance on Developing a National Plan for Preventing, Detecting and Responding to Actions, Activities and Behaviours That Result in Substandard/Spurious/Falsely-labelled/Falsified/Counterfeit (Ssffc) Medical Products. Appendix 2: Available Authentication Technologies for the Prevention and Detection of (Ssffc) Medical Products. Appendix 3: Who Member State Mechanism on Substandard/Spurious/Falsely-labelled/Falsified/Counterfeit (Ssffc) Medical Products: Working Definitions) [Arabic] [Chinese] [French] [Russian] [Spanish]

Year:

2017;

Pages:

42;


Related documents:

Regions:

 
Open this document and view its content

A70/23 - Member State mechanism on substandard/spurious/falsely-labelled/falsified/ counterfeit medical products. Report by the Director-General. Seventieth World Health Assembly, 2017. (with A70/23 Add.1 - Review of the Member State mechanism on substandard/spurious/falsely-labelled/ falsified/counterfeit medical products) (with Appendix 1: Guidance on developing a national plan for preventing, detecting and responding to actions, activities and behaviours that result in substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products. Appendix 2: Available authentication technologies for the prevention and detection of (SSFFC) medical products. Appendix 3: WHO member state mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products: Working definitions) (Arabic version) [Chinese] [English] [French] [Russian] [Spanish]

Year:

2017;

Pages:

45;


Related documents:

Regions:

 
Open this document and view its content

A70/23 - Member State mechanism on substandard/spurious/falsely-labelled/falsified/ counterfeit medical products. Report by the Director-General. Seventieth World Health Assembly, 2017. (with A70/23 Add.1) (Chinese version) A70/23 - 劣质、假造、标签不当、伪造、假冒 医疗产品问题会员国机制. 总干事的报告. 第七十届世界卫生大会, 2017. (A70/23 Add.1) (Chinese version) -关于劣质、假造、标签不当、伪造、假冒医疗产品问题会员国机制第五次会议的报告. 附录1 关于制定国家计划预防、发现和应对导致劣质、假造、标签不当、伪造、 假冒医疗产品的行动、活动和行为的指导. 附录2 预防和发现劣质、假造、标签不当、伪造、假冒医疗产品的现有认证技术. 附录3劣质、假造、标签不当、伪造、假冒医疗产品问题世卫组织会员国机制. 工作定义 [Arabic] [English] [French] [Russian] [Spanish]

Year:

2017;

Pages:

47;


Related documents:

Regions:

 
Open this document and view its content

A70/23 - Member State mechanism on substandard/spurious/falsely-labelled/falsified/ counterfeit medical products. Report by the Director-General. Seventieth World Health Assembly, 2017. (with A70/23 Add.1) (Russian version) A70/23 - МЕХАНИЗМ ГОСУДАРСТВ-ЧЛЕНОВ ПО НЕКОНДИЦИОННОЙ/ПОДДЕЛЬНОЙ/ЛОЖНО МАРКИРОВАННОЙ/ФАЛЬСИФИЦИРОВАННОЙ/ КОНТРАФАКТНОЙ МЕДИЦИНСКОЙ ПРОДУКЦИИ. ДОКЛАД ГЕНЕРАЛЬНОГО ДИРЕКТОРА. СЕМИДЕСЯТАЯ СЕССИЯ ВСЕМИРНОЙ АССАМБЛЕИ ЗДРАВООХРАНЕНИЯ, 2017. ВКЛЮЧЕНЫ (A70/23 Add.1) ДОБАВЛЕНИЕ 1 РУКОВОДСТВО ПО РАЗРАБОТКЕ НАЦИОНАЛЬНОГО ПЛАНА ПО ПРЕДОТВРАЩЕНИЮ, ВЫЯВЛЕНИЮ И ПРЕСЕЧЕНИЮ МЕР, ВИДОВ ДЕЯТЕЛЬНОСТИ И ФОРМ ПОВЕДЕНИЯ, КОТОРЫЕ ПРИВОДЯТ К СОЗДАНИЮ НЕКОНДИЦИОННОЙ/ПОДДЕЛЬНОЙ/ЛОЖНО МАРКИРОВАННОЙ/ФАЛЬСИФИЦИРОВАННОЙ/КОНТРАФАКТНОЙ МЕДИЦИНСКОЙ ПРОДУКЦИИ (НПЛФК). ДОБАВЛЕНИЕ 2 ИМЕЮЩИЕСЯ ТЕХНОЛОГИИ АУТЕНТИФИКАЦИИ В ИНТЕРЕСАХ ПРЕДОТВРАЩЕНИЯ ПОЯВЛЕНИЯ НА РЫНКЕ И ВЫЯВЛЕНИЯ МЕДИЦИНСКОЙ ПРОДУКЦИИ НПЛФК ДОБАВЛЕНИЕ 3 МЕХАНИЗМ ГОСУДАРСТВ-ЧЛЕНОВ ВОЗ ПО НЕКОНДИЦИОННОЙ/ПОДДЕЛЬНОЙ/ЛОЖНО МАРКИРОВАННОЙ/ФАЛЬСИФИЦИРОВАННОЙ/КОНТРАФАКТНОЙ МЕДИЦИНСКОЙ ПРОДУКЦИИ (НПЛФК). РАБОЧИЕ ОПРЕДЕЛЕНИЯ [Arabic] [Chinese] [English] [French] [Spanish]

Year:

2017;

Pages:

54;


Related documents:

Regions:

 
Open this document and view its content

Alternative Regulatory Models for Pharmaceutical Promotions Involving Civil Society and Other Non-Government Stakeholders

Year:

2015;

Pages:

99;


Regions:

Countries:

 
Open this document and view its content

Assessment of Regulatory Impacts on Pharmaceutical Promotion. Bishkek, 2015 - Kyrgyzstan

Year:

2015;

Pages:

60;


Countries:

 
Open this document and view its content

How Pharmaceutical Systems Are Organized in Asia and the Pacific. Manila: World Health Organization Regional Office for the Western Pacific; 2018

Year:

2018;

Pages:

44;


Related documents:

 
Open this document and view its content

Legislación reglamentaria nacional en materia de fármacos: Principios orientadores para pequeños servicios de reglamentación farmacéutica. OMS, Serie de Informes Técnicos, No. 885, 1999, Annex 8 [English]

Year:

1999;

Pages:

44;


Related documents:

Regions:

 
Open this document and view its content

National Drug Regulatory Legislation: Guiding Principles for Small Drug Regulatory Authorities. WHO Technical Report Series, No. 885, 1999, Annex 8 [Spanish]

Year:

1999;

Pages:

41;


Related documents:

Regions:

 
Open this document and view its content

Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries. A Systematic Review and Meta-analysis

Year:

2018;

Pages:

22;

Related documents:

Regions:

 
Open this document and view its content

SIAPS’ Technical Assistance to Strengthen Medicines Regulation in Namibia: 2011–2017. December 2017

Year:

2017;

Pages:

33;


Countries:

 
Open this document and view its content

Strengthening the Capacity of the Namibia Medicines Regulatory Council in the Regulation of Antiretroviral Medicines and Other Essential Pharmaceuticals

Year:

2014;

Pages:

78;


Countries:

 
Open this document and view its content

A Study on the Public Health and Socioeconomic Impact of Substandard and Falsified Medical Products

Year:

2017;

Pages:

77;


Related documents:

Regions:

 
Open this document and view its content

WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products

Year:

2017;

Pages:

73;


Related documents:

Regions:

 
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018